» Articles » PMID: 27164938

Acute Pericarditis-Associated Hospitalization in the USA: A Nationwide Analysis, 2003-2012

Overview
Journal Cardiology
Date 2016 May 12
PMID 27164938
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Epidemiologic data on hospitalizations for acute pericarditis are scarce. We sought to study the trends in these hospitalizations and outcomes in the USA over a 10-year period.

Methods: We used the 2003-2012 Nationwide Inpatient Sample database to identify admissions with a primary diagnosis of acute pericarditis. Outcomes included hospitalization rate, case fatality rate (CFR), length of stay (LOS), hospital charges, complications and diagnostic and therapeutic procedures.

Results: We observed an estimated 135,710 hospitalizations for acute pericarditis among patients ≥16 years during the study period (mean age 53.5 ± 18.5 years; 40.5% women). The incidence of acute pericarditis hospitalizations was significantly higher for men than for women [incidence rate ratio (IRR) 1.56; 95% confidence interval (CI) 1.54-1.58; p < 0.001]; it decreased from 66 to 54 per million person-years (p < 0.001). CFR and LOS declined significantly during the study period (CFR: 2.2% in 2003 to 1.4% in 2012; LOS: 4.8 days in 2003 to 4.1 days in 2012; p < 0.001 for both). The average inflation-adjusted health-care charge increased from USD 31,242 to 38,947 (p < 0.001).

Conclusion: The hospitalization rate, CFR and LOS associated with acute pericarditis have declined significantly in the US population. Average charges for acute pericarditis hospitalization have increased.

Citing Articles

Diversity in Acute Autoimmune Pericarditis: Nationwide Analysis of In-Hospital Outcomes and Recurrence.

Aikawa H, Fujino M, Nakao K, Nakai M, Kanaoka K, Sumita Y JACC Asia. 2024; 4(10):721-731.

PMID: 39553903 PMC: 11561515. DOI: 10.1016/j.jacasi.2024.06.008.


Pericardial Diseases Mortality Trends in Brazil From 2000 to 2022.

McBenedict B, Ahmed Y, Elmahdi R, Yusuf W, Netto J, Valentim G Cureus. 2024; 16(4):e57949.

PMID: 38738132 PMC: 11084855. DOI: 10.7759/cureus.57949.


JYNNEOS Vaccine Safety Surveillance During the 2022 Mpox Outbreak Using the Vaccine Adverse Event Reporting System and V-safe, United States, 2022 to 2023.

Duffy J, Myers T, Marquez P, Rouse D, Brown H, Zhang B Sex Transm Dis. 2024; 51(8):509-515.

PMID: 38647241 PMC: 11239308. DOI: 10.1097/OLQ.0000000000001978.


Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273.

Urdaneta V, Esposito D, Dharia P, Moraga M, Anteyi K, Oduyebo-Omotosho T Open Forum Infect Dis. 2024; 11(3):ofae067.

PMID: 38500575 PMC: 10946654. DOI: 10.1093/ofid/ofae067.


Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis.

Ling R, Ramanathan K, Tan F, Tai B, Somani J, Fisher D Lancet Respir Med. 2022; 10(7):679-688.

PMID: 35421376 PMC: 9000914. DOI: 10.1016/S2213-2600(22)00059-5.